JP2023541455A5 - - Google Patents
Info
- Publication number
- JP2023541455A5 JP2023541455A5 JP2023516736A JP2023516736A JP2023541455A5 JP 2023541455 A5 JP2023541455 A5 JP 2023541455A5 JP 2023516736 A JP2023516736 A JP 2023516736A JP 2023516736 A JP2023516736 A JP 2023516736A JP 2023541455 A5 JP2023541455 A5 JP 2023541455A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- cell
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063078134P | 2020-09-14 | 2020-09-14 | |
| US63/078,134 | 2020-09-14 | ||
| PCT/US2021/050341 WO2022056497A1 (en) | 2020-09-14 | 2021-09-14 | Single domain antibodies against cd33 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541455A JP2023541455A (ja) | 2023-10-02 |
| JP2023541455A5 true JP2023541455A5 (https=) | 2024-09-26 |
Family
ID=78080568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023516736A Pending JP2023541455A (ja) | 2020-09-14 | 2021-09-14 | Ｃｄ３３に対する単一ドメイン抗体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230365675A1 (https=) |
| EP (1) | EP4211164A1 (https=) |
| JP (1) | JP2023541455A (https=) |
| KR (1) | KR20230069961A (https=) |
| CN (1) | CN116615443A (https=) |
| AU (1) | AU2021340793A1 (https=) |
| CA (1) | CA3195367A1 (https=) |
| WO (1) | WO2022056497A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023010118A1 (en) * | 2021-07-29 | 2023-02-02 | Vor Biopharma Inc. | Nfat-responsive reporter systems for assessing chimeric antigen receptor activation and methods of making and using the same |
| WO2025030010A1 (en) | 2023-08-01 | 2025-02-06 | Vor Biopharma Inc. | Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereof |
| WO2026078018A1 (en) * | 2024-10-07 | 2026-04-16 | Fundación Para La Investigación Médica Aplicada | Cd33 specific single domain antibodies (sdab), cars and other products derived therefrom, and their uses in therapy and diagnosis |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL79289A (en) | 1985-07-05 | 1992-01-15 | Whitehead Biomedical Inst | Introduction and expression of foreign genetic material into keratinocytes using a recombinant retrovirus |
| US4980286A (en) | 1985-07-05 | 1990-12-25 | Whitehead Institute For Biomedical Research | In vivo introduction and expression of foreign genetic material in epithelial cells |
| US5219740A (en) | 1987-02-13 | 1993-06-15 | Fred Hutchinson Cancer Research Center | Retroviral gene transfer into diploid fibroblasts for gene therapy |
| ATE117375T1 (de) | 1987-09-11 | 1995-02-15 | Whitehead Biomedical Inst | Transduktionsveränderte fibroblasten und ihre anwendung. |
| JP2914692B2 (ja) | 1987-12-11 | 1999-07-05 | ホワイトヘツド・インスチチユート・フオー・バイオメデイカル・リサーチ | 内皮細胞の遺伝子修飾 |
| WO1989007136A2 (en) | 1988-02-05 | 1989-08-10 | Whitehead Institute For Biomedical Research | Modified hepatocytes and uses therefor |
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| ES2096750T3 (es) | 1990-10-31 | 1997-03-16 | Somatix Therapy Corp | Vectores retroviricos utiles para la terapia genica. |
| SE9201984D0 (sv) | 1992-06-29 | 1992-06-29 | Pharmacia Biosensor Ab | Improvement in optical assays |
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| US5308341A (en) | 1993-09-28 | 1994-05-03 | Becton, Dickinson And Company | Method of testing the dose accuracy of a medication delivery device |
| US6146361A (en) | 1996-09-26 | 2000-11-14 | Becton Dickinson And Company | Medication delivery pen having a 31 gauge needle |
| US6302855B1 (en) | 1998-05-20 | 2001-10-16 | Novo Nordisk A/S | Medical apparatus for use by a patient for medical self treatment of diabetes |
| US6192891B1 (en) | 1999-04-26 | 2001-02-27 | Becton Dickinson And Company | Integrated system including medication delivery pen, blood monitoring device, and lancer |
| US6277099B1 (en) | 1999-08-06 | 2001-08-21 | Becton, Dickinson And Company | Medication delivery pen |
| WO2003022330A2 (en) | 2001-09-12 | 2003-03-20 | Becton, Dickinson And Company | Microneedle-based pen device for drug delivery and method for using same |
| FR2849436B1 (fr) | 2002-12-27 | 2007-01-05 | Patrick Frayssinet | Particules et ceramiques de phosphates de calcium pour transfection in vivo et in vitro |
| EP2655624B1 (en) | 2010-12-23 | 2017-11-29 | Biogen MA Inc. | Linker peptides and polypeptides comprising same |
| US10508143B1 (en) | 2015-10-30 | 2019-12-17 | Aleta Biotherapeutics Inc. | Compositions and methods for treatment of cancer |
| CN108472365A (zh) | 2015-10-30 | 2018-08-31 | 艾丽塔生物治疗剂公司 | 用于肿瘤转导的组合物和方法 |
| US20200306375A1 (en) | 2017-02-22 | 2020-10-01 | Aleta Biotherapeutics Inc. | Compositions and methods for tumor transduction |
| AU2018225164A1 (en) | 2017-02-22 | 2019-09-19 | Aleta Biotherapeutics Inc. | Compositions and methods for treatment of cancer |
| EA202092044A1 (ru) | 2018-03-14 | 2021-03-03 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерные рецепторы антигена против cd33 и их применения |
| EP3850013A4 (en) * | 2018-09-10 | 2022-10-05 | Nanjing Legend Biotech Co., Ltd. | SINGLE DOMAIN ANTIBODIES AGAINST CLL1 AND USES THEREOF |
-
2021
- 2021-09-14 KR KR1020237012283A patent/KR20230069961A/ko active Pending
- 2021-09-14 CA CA3195367A patent/CA3195367A1/en active Pending
- 2021-09-14 WO PCT/US2021/050341 patent/WO2022056497A1/en not_active Ceased
- 2021-09-14 JP JP2023516736A patent/JP2023541455A/ja active Pending
- 2021-09-14 CN CN202180075831.3A patent/CN116615443A/zh active Pending
- 2021-09-14 US US18/026,036 patent/US20230365675A1/en active Pending
- 2021-09-14 EP EP21787236.5A patent/EP4211164A1/en active Pending
- 2021-09-14 AU AU2021340793A patent/AU2021340793A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7461950B2 (ja) | Ｃｄ３抗体およびその医薬用途 | |
| JP7682789B2 (ja) | Ｂ７－Ｈ３のＩｇＶドメインに対するモノクローナル抗体及びその使用 | |
| RU2766094C2 (ru) | Антитела, нацеленные на антиген созревания в-клеток, и способы их применения | |
| KR102022734B1 (ko) | 신규 조절제 및 용법 | |
| CN112969476B (zh) | 多特异性蛋白分子 | |
| JP2021525546A5 (https=) | ||
| JP2021531005A5 (https=) | ||
| JP2015163068A5 (https=) | ||
| JP2020510422A5 (https=) | ||
| JP2021508469A5 (https=) | ||
| JP2020525032A5 (https=) | ||
| KR20180089497A (ko) | Fc 수용체-유사 5를 표적화하는 항체 및 사용 방법 | |
| BR112021009325A2 (pt) | Anticorpo monoclonal, ou fragmento de ligação ao antígeno do mesmo; anticorpo biespecífico; método para prevenir ou tratar um câncer suscetível em um ser humano; método de ensaio de expressão de sirp¿ em células tumorais e/ou imunes; e; composição farmacêutica | |
| JP2023541455A5 (https=) | ||
| EP3359565A1 (en) | Anti-wt1/hla-specific antibodies | |
| JP2017535257A5 (https=) | ||
| TW201829467A (zh) | 抗ｃｄ３抗體及含有該抗體的分子 | |
| JP2013527762A5 (https=) | ||
| JP2023540526A5 (https=) | ||
| JP2022514734A5 (https=) | ||
| JP2021512604A5 (https=) | ||
| JP2024518776A5 (https=) | ||
| JP2024512135A5 (https=) | ||
| JP2016529213A5 (https=) | ||
| JP2023509373A5 (https=) |